Allied Market Research

Global Motion Preservation Devices Market Expected to Reach $1,902 Million by 2022

LogoGlobal Motion Preservation Devices Market was valued at $920 million in 2015, and is projected to reach $1,902 million by 2022, registering a CAGR of 10.9% from 2016 to 2022, According to a new report published by Allied Market Research

Spine Bone Stimulators Market Is Expected to Reach $724 Million, Globally, by 2022

LogoSpine Bone Stimulators Market Report, published by Allied Market Research, forecasts that the global market was valued at $562 million in 2015, and is expected to reach $724 million by 2022, supported by a CAGR of 3.6% during the forecast period 2014 - 2022.

Catheters Market Expected to Reach $15,830 Million, Globally, by 2022

LogoCatheters Market Report, published by Allied Market Research, forecasts that the global market was valued at $8,905 million in 2015, and is expected to reach $15,830 million by 2022, supported by a CAGR of 8.5% during the forecast period 2014 - 2022. North America is the largest contributor in the catheter market; however, LAMEA is growing at the highest rate.

Asia-Pacific Medical Nonwoven Disposables Market Is Expected to Reach $3.3 Billion, by 2020

LogoAsia-Pacific Medical Nonwoven Disposables Market Report, published by Allied Market Research, forecasts that the market is expected to garner $3,374.9 million by 2020, registering a CAGR of 12.1% from 2015-2020. In 2014, surgical nonwovens segment accounted for about half of the Asia-Pacific medical nonwoven disposables market, largely due to the growing awareness for prevention of hospital acquired infections (HAI) and rising demand for sophisticated medical services.

Biosurgery Market Is Expected to Reach $12.7 Billion, Globally, by 2022

LogoBiosurgery Market report, published by Allied Market Research, forecasts that the global market is expected to garner $12,758.1 million by 2022, registering a CAGR of 8.1% during the period 2014 - 2022. Hemostatic and surgical sealing agents segment collectively held about half of the market share in 2015, which is expected to flourish over the forecast period. The neuro and spine surgery application segment is likely to lead the biosurgery market throughout the study period.

Food Stabilizer Market Expected to Reach $10,100 Million, Globally, by 2023

LogoFood Stabilizer Market Report, published by Allied Market Research, projects that the global market was valued at $7,580 million in 2016, and is estimated to reach $10,100 million by 2023, registering a CAGR of 4.1% from 2017 to 2023. In 2016, the gelatin food stabilizer type segment accounted for more than one-third share of the total market.

Market Sizing, Future Growth, New Trends, Key Players of the Global Data Science Platform Market

LogoAccording to a new report by Allied Market Research, titled, Data Science Platform Market by Type and End User: Global Opportunity and Forecast, 2017-2023, the data science platform market was valued at $19,621 million in 2016, and is projected to reach at $183,688 million by 2023, growing at a CAGR of 39.6% from 2017 to 2023.

Phytosterols Market by Material Type and Application Report

LogoAccording to a new report published by Allied Market Research, titled, Phytosterols Market by Market type and Application: Global Opportunity Analysis and Industry Forecast, 2014-2022, the global phytosterols market has generated $490 million in 2015, growing at a CAGR of 9.62% during the forecast period to reach $935 million by 2022. In 2015, Beta-sitosterols type occupied three-fifths share in terms of revenue.

Chemotherapy-Induced Nausea and Vomiting (CINV) Market Segments Overview

LogoChemotherapy-induced Nausea and Vomiting (CINV) Market report, published by Allied Market Research, forecasts that the global market is expected to garner $2,659 million by 2022, growing at a CAGR of 7.1% during 2016-2022.

HIV Drugs Market Growth Analysis Forecasts to 2022

LogoHIV Drug Market report, published by Allied Market Research, forecasts that the global market is expected to garner $26,458 million by 2022, registering a CAGR of 3.7% during the period 2016 - 2022. The multi-class combination drug segment held over one-third share of the total market in 2015.